Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126730481 | 12673048 | 1 | I | 20160816 | 20160822 | 20160822 | EXP | CA-JNJFOC-20160813875 | JANSSEN | 54.00 | YR | A | M | Y | 0.00000 | 20160822 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126730481 | 12673048 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 2 | MG | TABLETS | QD | |||||
| 126730481 | 12673048 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 2 | MG | TABLETS | QD | |||||
| 126730481 | 12673048 | 3 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 20272 | 2 | MG | TABLETS | QD | |||||
| 126730481 | 12673048 | 4 | SS | INVEGA | PALIPERIDONE | 1 | Oral | U | U | 0 | 12 | MG | PROLONGED-RELEASE TABLET | ||||||
| 126730481 | 12673048 | 5 | SS | INVEGA | PALIPERIDONE | 1 | Oral | U | U | 0 | 12 | MG | PROLONGED-RELEASE TABLET | ||||||
| 126730481 | 12673048 | 6 | SS | INVEGA | PALIPERIDONE | 1 | Oral | U | U | 21999 | 12 | MG | PROLONGED-RELEASE TABLET | ||||||
| 126730481 | 12673048 | 7 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 12 | MG | UNSPECIFIED | |||||||
| 126730481 | 12673048 | 8 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 10 | MG | UNSPECIFIED | |||||||
| 126730481 | 12673048 | 9 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 12 | MG | UNSPECIFIED | |||||||
| 126730481 | 12673048 | 10 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 10 | MG | UNSPECIFIED | |||||||
| 126730481 | 12673048 | 11 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 10 | MG | UNSPECIFIED | |||||||
| 126730481 | 12673048 | 12 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 12 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126730481 | 12673048 | 1 | Anxiety |
| 126730481 | 12673048 | 2 | Depression |
| 126730481 | 12673048 | 3 | Psychotic disorder |
| 126730481 | 12673048 | 4 | Anxiety |
| 126730481 | 12673048 | 5 | Depression |
| 126730481 | 12673048 | 6 | Psychotic disorder |
| 126730481 | 12673048 | 7 | Anxiety |
| 126730481 | 12673048 | 8 | Anxiety |
| 126730481 | 12673048 | 9 | Depression |
| 126730481 | 12673048 | 10 | Depression |
| 126730481 | 12673048 | 11 | Psychotic disorder |
| 126730481 | 12673048 | 12 | Psychotic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126730481 | 12673048 | DS |
| 126730481 | 12673048 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126730481 | 12673048 | Blood glucose increased | |
| 126730481 | 12673048 | Muscle spasms | |
| 126730481 | 12673048 | Musculoskeletal stiffness | |
| 126730481 | 12673048 | Restlessness | |
| 126730481 | 12673048 | Somnolence | |
| 126730481 | 12673048 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |